BERKELEY, Calif., June 15, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced that a NASDAQ Listing Qualifications Panel (the “Panel”) has granted the company’s request for an extension of time, as permitted under NASDAQ’s Listing Rules, to comply with the $1.00 per share minimum bid price requirement for continued listing. In accordance with the Panel’s decision, on or before September 13, 2010, the company must evidence a closing bid price of $1.00 or more for a minimum of ten consecutive trading days or its common shares will be subject to delisting from The NASDAQ Global Market. Under NASDAQ’s rules, this date represents the maximum length of time that a Panel may grant to regain compliance.
